New study shows higher efficacy of AstraZeneca in mix-and-match with Medigen
12/04/2021 08:01 PM
A recent COVID-19 vaccine trial carried out in Taiwan has found that a mix of AstraZenca and the locally developed Medigen is more effective than two doses AstraZeneca, the head of the research team said Saturday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Culture
Tamkang, Sorbonne academics receive Taiwan-France Cultural Award
09/15/2026 04:09 PM - Business
Micron Taiwan union rejects one-time reward package
09/15/2026 03:23 PM - Politics
Taiwan 7th worldwide for citizen input, slips in judicial freedom
09/15/2026 02:59 PM - Society
Wildlife campaigners call for proactive over reactive policymaking
09/15/2026 02:46 PM - Business
Taiwan shares close down 0.77%
09/15/2026 01:57 PM